Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.
AUTOR(ES)
Baber, N S
RESUMO
A multicentre study of survivors of an anterior myocardial infarction is reported. The trial consisted of 720 patients and was a double-blind, placebo-controlled study with propranolol 40 mg three times a day. Trial entry was at two to 14 days (mean 8.5 days) and follow-up at one, three, and in most centres, six and nine months. The trial was designed to detect a 50 per cent reduction in mortality and this was not shown. The non-fatal reinfarction rate was similar in both groups. Subgroup analysis identified several prognostic risk factors for death, none of which interacted with treatment.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=482366Documentos Relacionados
- Elective operations for post-infarction left ventricular aneurysms.
- Alternative surgical management of post-infarction septal rupture: a case report.
- Aggressive Surgical Management of Post-Infarction Angina: Results of Myocardial Revascularization Early After Transmural Infarction
- Time course of ventricular arrhythmias and the signal averaged electrocardiogram in the post-infarction period: a prospective study of correlation.
- Myocardial ischaemia and angina in the early post-infarction period: a comparison with patients with stable coronary artery disease.